Molecular Insights into Cancer Biomarkers: Identification and Practical Applications
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 July 2025 | Viewed by 540
Special Issue Editor
Interests: immunology and immune response during viral infections; oncology; immunotherapy; intracellular signalling; targeted therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nowadays, cancer research is evolving, and the identification of new biomarkers that can provide early cancer detection, predict its progression, or assist in treatment monitoring—preferably in a non-invasive manner—is transforming the oncology field in terms of diagnosis, prognosis, and treatment strategies. This Special Issue will focus on the discovery, validation, and clinical application of cancer biomarkers, with an emphasis on their role in tumor growth, progression, metastasis, and therapeutic intervention. This issue aims to highlight cutting-edge research on the identification of novel cancer biomarkers and their roles in tumor progression and metastasis, tissue matrix remodeling proteins and their significance in cancer metastasis, and biomarker-based therapeutic strategies. Also, a special emphasis will be placed on liquid biopsy biomarkers, with applications for monitoring tumor dynamics and therapeutic response.
This Special Issue should appeal to a broad audience of oncologists, molecular biologists, and translational researchers, driving forward the integration of biomarkers into precision oncology.
Dr. Mihaela Chivu-Economescu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer biomarkers
- liquid biopsy
- early detection
- progression
- prognosis
- treatment monitoring
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
